Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications: supplementary materials

dataset

posted on 2024-05-02, 14:01 authored by Maria Jose Labis da Costa, Gesiane Nascimento, Thannuse Athie, Juliana de Sales Silva, Edna Afonso Reis, Antony Martin, Brian Godman, Isabella Piassi Dias Godoi

These are peer-reviewed supplementary materials for the article 'Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications' published in the Journal of Comparative Effectiveness Research.

Previous knowledge about malaria
Information about malaria
Conference about context understanding
Opinion research
Clinical data
Exclusive to interviewer

Aim: Malaria is an infection caused by protozoa of genus Plasmodium, considered the one associated with increasingly large outbreaks. Methods: A cross-sectional study was conducted with residents in the northern region of Brazil on the willingness to pay (WTP) for a hypothetical vaccine against malaria (effective protection of 80%). Results: Of 616 people interviewed, most interviewees were female (61%) and were employed (97%). The median individual maximum WTP for a hypothetical malaria vaccine was US$11.90 (BRL 50). Conclusion: The northern region of Brazil is one of the largest markets for a malaria vaccine due to its epidemiological relevance. Consequently, economic studies will be important to assist in the assessment of the potential price and value of new vaccines.